--- title: 'Senior Director, US Marketing, Inborn Errors of Metabolism at Ultragenyx Pharmaceutical' canonical: 'https://feeny.ai/job/senior-director-us-marketing-inborn-errors-of-metabolism-ultragenyx-qfhmhx57fftq' type: 'job' last_seen: '2026-11-09' --- # Senior Director, US Marketing, Inborn Errors of Metabolism at Ultragenyx Pharmaceutical - **Company:** Ultragenyx Pharmaceutical - **Location:** United States - **Compensation:** $247k–$305k - **Work type:** remote - **Posted:** 2026-07-31 - **Last confirmed live:** 2026-11-09 - **Apply:** https://job-boards.greenhouse.io/ultragenyxpharmaceutical/jobs/4719200005?gh_jid=4719200005 ## Job description Why Join Us? Be a hero for our rare disease patients At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work. If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team. Position Summary: ultrainnovative – Tackle rare and dynamic challenges Reporting to the US Marketing Lead, the Senior Director of US Marketing will direct all Marketing initiatives for the continued successful commercialization of Dojolvi and Mepsevii in the US market. The Senior Director will lead the development and execution of best-in-class annual marketing plans inclusive of market conditioning and development, disease education, brand strategies and tactical plans for the IEM programs utilizing deep marketing knowledge and former successful metabolic rare disease & biopharmaceutical marketing experience. The Senior Director is responsible for the implementation of the brand strategy and corresponding tactics for the ongoing commercialization of both brands. The successful individual will work cross-functionally with Medical Affairs, Global Brand Strategy, Marketing Research, Market Access, Patient Services, Regulatory, Legal, Compliance, Clinical Development, and Supply Chain and will work with other members of the commercial services team as needed. The individual will lead projects through the Materials and Medical Review process. Work Model: Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed. Responsibilities: - The Senior Director is responsible for leading Dojolvi/Mepsevii marketing team. - The Senior Marketing Director is jointly responsible with the Medical Director, Medical affairs for leading the North American Franchise Team (NAFT) - Work closely with the Marketing Lead and National Field Director to lead the US marketing initiatives, monitor the progress of these marketing initiatives and adjust appropriately to optimize patient access and key customer uptake - Leads the development of annual brand plans and associated budgets and is responsible for managing execution against plans and budgets, overseeing and managing brand budgets, and ensure on-time delivery within budget of all marketing initiatives - Lead execution of U.S. brand strategy, including patient support, professional communications, and KOL engagement, ensuring alignment with global brand plans. - Develop and implement impactful brand and market development initiatives, using clear metrics to measure performance and optimize results. - Partner cross-functionally across Commercial, Medical, Regulatory, Legal, Compliance, Patient Advocacy, and Global teams to drive strategic objectives. - Identify and address barriers to patient access, collaborating with field teams to advance disease awareness, product adoption, and the patient journey. - Ensure all promotional activities and commercial decisions comply with regulatory requirements and support product lifecycle management. Requirements: - BA/BS degree or equivalent life-sciences qualification required. MBA preferred. - Minimum 12+ years of sales and marketing experience in the biopharmaceutical industry with at least 5 years in rare/ultra-rare disease, experience with Metabolic Genetics highly desirable. Significant successful launch experience required. Direct sales experience strongly preferred. - Successful candidates will have a proven ability to work in a multidisciplinary team with a high degree of collaborations, a strong patient focus and an understanding of U.S. patient access challenges. - Strong command of analytical and market research techniques with a proven ability to interpret market insights to help guide strategic direction and prioritize tactics. - Experience managing agency partners and external vendors. - Strategic thinker with a track record of developing and executing innovative brand strategies. - Strong analytical, problem-solving, and business acumen with solid scientific knowledge. - Proven ability to influence, collaborate, and negotiate across cross-functional stakeholders in a fast-paced environment. - Effective leader with excellent presentation, communication, and relationship-building skills - This position will require a minimum of 30% travel in the US #LI-MD1 #LI-Remote The typical annual salary range for this full-time position is listed below. This range reflects the characteristics of the job, such as required skills and qualifications and is based on the office location noted in this job posting. The range may also be adjusted based on applicant's geographic location. This position is eligible for annual bonus and equity incentives. Actual individual pay is determined by demonstrated experience and internal equity alignment. Pay Range $247,300—$305,400 USD Full Time employees across the globe enjoy a range of benefits, including, but not limited to: - Generous vacation time and public holidays observed by the company - Volunteer days - Long term incentive and Employee stock purchase plans or equivalent offerings - Employee wellbeing benefits - Fitness reimbursement - Tuition sponsoring - Professional development plans - Benefits vary by region and country Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at talentacquisition@ultragenyx.com. See our [CCPA Employee and Applicant Privacy Notice](https://www.ultragenyx.com/CCPA-Notice/). See our [Privacy Policy](https://www.ultragenyx.com/privacy-policy/). Note to External Recruiters: All candidate activity and open positions are managed strictly through our Human Resources Department. Our Human Resources Department kindly requests that recruiters not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Please note that failure to comply with this request will be a factor in determining a professional relationship with our organization. Submission of unsolicited resumes prior to an agreement set in place between the Human Resources Department and the recruiting agency will not create any implied obligation.  Inquiries on developing a recruiting relationship with us, may be directed to: [talentacquisition@ultragenyx.com](http://mailto:talentacquisition@ultragenyx.com/). ## About Ultragenyx Pharmaceutical ## Company Overview - **One-liner**: Ultragenyx Pharmaceutical is a biopharmaceutical company dedicated to developing and commercializing first-ever treatments for rare and ultra-rare genetic diseases with high unmet medical need. - **Entity Type**: Public (NASDAQ: RARE) - **Headquarters**: Novato, California, United States - **Founded**: 2010 - **Founders**: Emil D. Kakkis, M.D., Ph.D. ## Core Business - **Primary industry/industries**: Biotechnology research; rare disease therapeutics (metabolic, bone, endocrine, muscle, and central nervous system disorders). - **Target customers**: B2B (healthcare providers, payers, government agencies) and B2C (patients and patient advocacy groups). - **Mission or purpose statement**: “Transform the lives of those living with rare diseases” (ultragenyx.com). ## Products & Services - **Crysvita (burosumab)**: Approved for X-linked hypophosphatemia (XLH) – a biologic therapy. - **Dojolvi (triheptanoin)**: Approved for long-chain fatty acid oxidation disorders (LC-FAOD) – a small molecule. - **Mepsevii (vestronidase alfa)**: Approved for mucopolysaccharidosis VII (Sly syndrome) – an enzyme replacement therapy. - **Evinacumab-dgnb (non-U.S. rights)**: Approved by FDA and EMA for homozygous familial hypercholesterolemia; marketed outside the U.S. under a partnership with Regeneron. - **Pipeline**: A diverse portfolio across multiple modalities – gene therapies, antisense oligonucleotides (ASOs), mRNA therapies – targeting ultra-rare diseases in bone, endocrine, metabolic, muscle, and CNS categories (ultragenyx.com). ## Market Standing - **Valuation/Market Cap**: ~$3.3 billion (as of June 2026, per LinkedIn company page and market data). - **Key Metric**: Annual revenue of $673 million (most recent fiscal year); total funding of $1.55 billion (including Series A, post-IPO equity, and debt). - **Notable Investors/Partners**: - Investors: Ontario Municipal Employees Retirement System (led $400M post-IPO debt in 2025), multiple venture and institutional investors. - Partners: Kyowa Hakko Kirin, Daiichi Sankyo, Mereo BioPharma, Regeneron (non-U.S. commercial rights for evinacumab). - **Growth Signals**: - One of the largest and most diverse pipelines in rare disease. - Awarded “Best Place to Work” by BioSpace (2020, 2021) and recognized by Deloitte’s Fast 500. - Active job postings: 21 openings as of mid-2026 (LinkedIn), though headcount declined 1.9% YoY to 1,247 employees. - Recent news: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5 (June 2026). ## Competitive Advantages - **Ultra-rare focus**: Targets diseases with no approved therapies, creating first-ever treatments and building significant regulatory and commercial expertise. - **Multi-modality platform**: Expertise across biologics, small molecules, gene therapies, ASOs, and mRNA – reducing risk and expanding addressable disease space. - **Global infrastructure**: Operations in 20 countries (including Brazil, Switzerland, Mexico, Japan) and commercial presence in North America, Europe, Latin America, and Asia. ## Strategic Focus - **Commercial expansion**: Hiring for Commercial and Medical Affairs teams to support growing product portfolio. - **Gene therapy manufacturing**: Building a new gene therapy manufacturing facility in the Boston area to scale production for pipeline candidates. - **Pipeline advancement**: Continued clinical development of gene therapies, ASOs, and mRNA programs for ultra-rare indications. ## Why Work Here - **Culture**: Described as “inclusive, generous, curious, and humble,” with a strong emphasis on purpose and patient impact. Named a top workplace by BioSpace and Deloitte. - **Benefits**: Comprehensive coverage starting on day one for all regular full-time employees; includes robust health, retirement, and wellness programs. - **Work environment**: Hybrid/office model with multiple U.S. hubs (Novato, Brisbane, Boston area) and international offices. Employer rating on LinkedIn: 3.3/5 (324 reviews) with culture rated 3.5, compensation 4.0, and work-life balance 3.2. - **Career development**: Internships, seasonal co-ops, and postdoctoral programs; strong alumni pipeline to top biopharma companies (Genentech, BioMarin, Vertex, Amgen). ## Sources 1. [ultragenyx.com](https://www.ultragenyx.com/) 2. [ultragenyx.com – Join Our Team](https://www.ultragenyx.com/join-our-team/) 3. [ultragenyx.com – Current Opportunities](https://www.ultragenyx.com/join-our-team/current-opportunities/) 4. [LinkedIn Company Page](https://www.linkedin.com/company/ultragenyx) 5. [talent.ultragenyx.com](https://talent.ultragenyx.com/) 6. [Greenhouse Careers Page](https://job-boards.greenhouse.io/ultragenyxpharmaceutical) ## Other roles at Ultragenyx Pharmaceutical - [Key Account Manager](https://feeny.ai/job/key-account-manager-ultragenyx-pharmaceutical-greater-london-mp9xb7agphnn) — Greater London, United Kingdom - [UltraCare Liaison (Atlanta)](https://feeny.ai/job/ultracare-liaison-atlanta-ultragenyx-pharmaceutical-united-states-9bsg49pqe04j) — United States - [Senior Manager, Drug Substance Manufacturing Upstream](https://feeny.ai/job/senior-manager-drug-substance-manufacturing-upstream-ultragenyx-pharmaceutical-avf8j7sg57qn) — Bedford, MA - [Manager, Drug Product Manufacturing](https://feeny.ai/job/manager-drug-product-manufacturing-ultragenyx-pharmaceutical-bedford-tmtndeam8yev) — Bedford, MA - [Senior Medical Science Manager North UK](https://feeny.ai/job/senior-medical-science-manager-north-uk-ultragenyx-pharmaceutical-united-kingdom-rd4ajn23t7z4) — United Kingdom - [UltraCare Liaison](https://feeny.ai/job/ultracare-liaison-ultragenyx-pharmaceutical-germany-b502ttkt7d2w) — Germany